How should one think about building "the new wave" of biopharma teams? Turns out we can rely on principles from existing domains. In this episode, I talk with Ankit Gupta, CTO and Co-Founder of Reverie Labs, on systematization as a foundation, and on optimizing properties of a drug using machine learning and software-oriented frameworks.
Check out the glossary of terms, definitions, and resources (and get a sneak peak of the future conversations lined up!) here: bit.ly/datapulse-glossary
